HEADER HYDROLASE 20-MAR-07 2P7U TITLE THE CRYSTAL STRUCTURE OF RHODESAIN, THE MAJOR CYSTEINE PROTEASE OF T. TITLE 2 BRUCEI RHODESIENSE, BOUND TO INHIBITOR K777 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTEINE PROTEASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI RHODESIENSE; SOURCE 3 ORGANISM_TAXID: 31286; SOURCE 4 STRAIN: RHODESIENSE; SOURCE 5 GENE: RHODESAIN; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPIC Z KEYWDS CYSTEINE PROTEASE, TRYPANOSOMA BRUCEI, NEGLECTED DISEASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.S.BRINEN,R.MARION REVDAT 5 30-AUG-23 2P7U 1 REMARK REVDAT 4 20-OCT-21 2P7U 1 REMARK SEQADV LINK REVDAT 3 29-SEP-09 2P7U 1 JRNL REVDAT 2 24-FEB-09 2P7U 1 VERSN REVDAT 1 25-MAR-08 2P7U 0 JRNL AUTH I.D.KERR,J.H.LEE,C.J.FARADY,R.MARION,M.RICKERT,M.SAJID, JRNL AUTH 2 K.C.PANDEY,C.R.CAFFREY,J.LEGAC,E.HANSELL,J.H.MCKERROW, JRNL AUTH 3 C.S.CRAIK,P.J.ROSENTHAL,L.S.BRINEN JRNL TITL VINYL SULFONES AS ANTIPARASITIC AGENTS AND A STRUCTURAL JRNL TITL 2 BASIS FOR DRUG DESIGN. JRNL REF J.BIOL.CHEM. V. 284 25697 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19620707 JRNL DOI 10.1074/JBC.M109.014340 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 89.5 REMARK 3 NUMBER OF REFLECTIONS : 17747 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.137 REMARK 3 R VALUE (WORKING SET) : 0.135 REMARK 3 FREE R VALUE : 0.175 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 950 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1211 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.51 REMARK 3 BIN R VALUE (WORKING SET) : 0.1990 REMARK 3 BIN FREE R VALUE SET COUNT : 70 REMARK 3 BIN FREE R VALUE : 0.3210 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1604 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 169 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.26000 REMARK 3 B22 (A**2) : -0.41000 REMARK 3 B33 (A**2) : 0.57000 REMARK 3 B12 (A**2) : 0.17000 REMARK 3 B13 (A**2) : 0.51000 REMARK 3 B23 (A**2) : 0.28000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.099 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.098 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.055 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.580 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1714 ; 0.020 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1081 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2342 ; 1.673 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2656 ; 1.665 ; 3.005 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 220 ; 5.671 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 79 ;41.843 ;26.709 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 249 ;12.812 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 2 ;20.611 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 248 ; 0.110 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1974 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 325 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 350 ; 0.209 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1115 ; 0.193 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 847 ; 0.182 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 812 ; 0.094 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 85 ; 0.177 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 3 ; 0.244 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 18 ; 0.277 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.248 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1369 ; 1.543 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 450 ; 0.344 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1712 ; 1.904 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 768 ; 3.170 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 627 ; 4.593 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2P7U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1000042075. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-00 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18751 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.7 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.14700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1F2A WITHOUT INHIBITOR OR WATERS, WITH SIDE CHAINS REMARK 200 THAT DIFFER CUT BACK TO ALANINE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0 M SODIUM CITRATE; IMIDAZOLE PH REMARK 280 8.00, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 21 53.37 -94.98 REMARK 500 MET A 103 91.75 30.90 REMARK 500 ASN A 104 103.74 -166.71 REMARK 500 ASP A 114 -179.83 -172.79 REMARK 500 ALA A 172 54.47 -98.16 REMARK 500 SER A 185 163.55 80.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D1R A 300 DBREF 2P7U A 1 215 UNP Q95PM0 Q95PM0_TRYBR 126 340 SEQADV 2P7U ALA A 172 UNP Q95PM0 SER 297 ENGINEERED MUTATION SEQRES 1 A 215 ALA PRO ALA ALA VAL ASP TRP ARG GLU LYS GLY ALA VAL SEQRES 2 A 215 THR PRO VAL LYS ASP GLN GLY GLN CYS GLY SER CYS TRP SEQRES 3 A 215 ALA PHE SER THR ILE GLY ASN ILE GLU GLY GLN TRP GLN SEQRES 4 A 215 VAL ALA GLY ASN PRO LEU VAL SER LEU SER GLU GLN MET SEQRES 5 A 215 LEU VAL SER CYS ASP THR ILE ASP PHE GLY CYS GLY GLY SEQRES 6 A 215 GLY LEU MET ASP ASN ALA PHE ASN TRP ILE VAL ASN SER SEQRES 7 A 215 ASN GLY GLY ASN VAL PHE THR GLU ALA SER TYR PRO TYR SEQRES 8 A 215 VAL SER GLY ASN GLY GLU GLN PRO GLN CYS GLN MET ASN SEQRES 9 A 215 GLY HIS GLU ILE GLY ALA ALA ILE THR ASP HIS VAL ASP SEQRES 10 A 215 LEU PRO GLN ASP GLU ASP ALA ILE ALA ALA TYR LEU ALA SEQRES 11 A 215 GLU ASN GLY PRO LEU ALA ILE ALA VAL ASP ALA THR SER SEQRES 12 A 215 PHE MET ASP TYR ASN GLY GLY ILE LEU THR SER CYS THR SEQRES 13 A 215 SER GLU GLN LEU ASP HIS GLY VAL LEU LEU VAL GLY TYR SEQRES 14 A 215 ASN ASP ALA SER ASN PRO PRO TYR TRP ILE ILE LYS ASN SEQRES 15 A 215 SER TRP SER ASN MET TRP GLY GLU ASP GLY TYR ILE ARG SEQRES 16 A 215 ILE GLU LYS GLY THR ASN GLN CYS LEU MET ASN GLN ALA SEQRES 17 A 215 VAL SER SER ALA VAL VAL GLY HET D1R A 300 41 HETNAM D1R NALPHA-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]-N-{(1S)-3- HETNAM 2 D1R PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}-L- HETNAM 3 D1R PHENYLALANINAMIDE FORMUL 2 D1R C32 H40 N4 O4 S FORMUL 3 HOH *169(H2 O) HELIX 1 1 ARG A 8 GLY A 11 5 4 HELIX 2 2 SER A 24 ALA A 41 1 18 HELIX 3 3 SER A 49 ASP A 57 1 9 HELIX 4 4 PHE A 61 GLY A 65 5 5 HELIX 5 5 LEU A 67 ASN A 79 1 13 HELIX 6 6 VAL A 92 GLY A 96 5 5 HELIX 7 7 ASP A 121 GLY A 133 1 13 HELIX 8 8 ALA A 141 MET A 145 5 5 HELIX 9 9 ASN A 201 MET A 205 5 5 SHEET 1 A 3 ALA A 4 ASP A 6 0 SHEET 2 A 3 HIS A 162 ASN A 170 -1 O TYR A 169 N VAL A 5 SHEET 3 A 3 LEU A 135 VAL A 139 -1 N LEU A 135 O LEU A 166 SHEET 1 B 5 ALA A 4 ASP A 6 0 SHEET 2 B 5 HIS A 162 ASN A 170 -1 O TYR A 169 N VAL A 5 SHEET 3 B 5 TYR A 177 LYS A 181 -1 O LYS A 181 N LEU A 165 SHEET 4 B 5 TYR A 193 GLU A 197 -1 O ILE A 194 N ILE A 180 SHEET 5 B 5 ILE A 151 LEU A 152 1 N LEU A 152 O GLU A 197 SHEET 1 C 2 ASN A 82 PHE A 84 0 SHEET 2 C 2 ILE A 108 ALA A 111 -1 O GLY A 109 N VAL A 83 SHEET 1 D 2 ASP A 114 ASP A 117 0 SHEET 2 D 2 SER A 210 VAL A 213 -1 O SER A 211 N VAL A 116 SSBOND 1 CYS A 22 CYS A 63 1555 1555 2.05 SSBOND 2 CYS A 56 CYS A 101 1555 1555 2.06 SSBOND 3 CYS A 155 CYS A 203 1555 1555 2.01 LINK SG CYS A 25 C27 D1R A 300 1555 1555 1.79 CISPEP 1 ASN A 174 PRO A 175 0 0.89 SITE 1 AC1 18 ALA A 3 GLN A 19 GLY A 23 CYS A 25 SITE 2 AC1 18 TRP A 26 CYS A 63 GLY A 64 GLY A 65 SITE 3 AC1 18 GLY A 66 LEU A 67 MET A 68 ALA A 138 SITE 4 AC1 18 ASP A 161 HIS A 162 TRP A 184 HOH A 434 SITE 5 AC1 18 HOH A 512 HOH A 607 CRYST1 34.377 39.716 39.566 120.38 93.89 101.18 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029089 0.005749 0.005927 0.00000 SCALE2 0.000000 0.025666 0.016047 0.00000 SCALE3 0.000000 0.000000 0.029877 0.00000